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Objective: Multidrug-resistant tuberculosis (MDR-TB) is caused byMycobacterium tuberculosis
strains that do not respond to isoniazid and rifampicin, the two most effective first-line
anti-TB drugs. Here, we designed and produced antibodies based on biomarkers that exist
only in MDR-TB.
Methods: Bacilli were cultured for 4 weeks at 37 C, and protein extraction was performed
by sequential extraction. Bacterial cells were sonicated, centrifuged at 5000 rpm for
45 min, and the supernatant was collected and subjected to multiple rounds of treatment
to prior to protein isolation. Protein concentration was determined using the Bradford
method, and extracted proteins (50 lg) from each strain (drug-sensitive- and MDR-TB iso-
lates) were visualized on polyacrylamide gels (5–15%) with Coomassie Brilliant Blue R-250
staining. Three extracts were mixed and dialyzed against 0.1 M ammonium bicarbonate
(pH 8.0), followed by mass spectrometry. Specific polyclonal antibodies against purified
MDR-TB proteins were purified by affinity chromatography and prepared in rabbits using
three booster injections. The ELIZA test was performed for evaluation the antibody produc-
tion. The antibody was treated with normal oral flora to remove any non specificity and
cross reactivity. Analyses of different protein patterns (drug-sensitive- and MDR-TB) were
performed by western blot.
Results: Our revealed that the MDR-TB strains contained specific antigens, and that the pro-
tein profiles of drug-sensitive TB strains differed from those of the MDR-TB isolates. Five
bands from the MDR-TB fractions were detected as diagnostic antigens and were not
observed in drug-sensitive-TB fractions. Western blot results showed that the MDR-TB anti-
genic fractions showed immunogenic bands at 50.0 kDa and 70.0 kDa, with the five antigenic
MDR-TB-specific bands were identified as Rv3248c, Rv0350, Rv0440, Rv0475, and Rv3588c.
Conclusion: Western blot data revealed dynamic properties of antibody responses that led to
actionable findings for further research. Moreover, specific anti-mycobacterial antibodies,
such as MDR-TB antibodies, can be essential tools in the identification of species-restricted
antigens, such as drug-resistant TB antigens. The MDR-TB antibodies described here might
promote identification ofmycobacterial antigens during the course of infection, which couldistry Lab., TB Dept., Pasteur Institute-Tehran, Iran.
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